Page last updated: 2024-11-05

tolazamide and Akinetic-Rigid Variant of Huntington Disease

tolazamide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies

Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Williams, A1
Sarkar, S1
Cuddon, P1
Ttofi, EK1
Saiki, S1
Siddiqi, FH1
Jahreiss, L1
Fleming, A1
Pask, D1
Goldsmith, P1
O'Kane, CJ1
Floto, RA1
Rubinsztein, DC1

Other Studies

1 other study available for tolazamide and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
    Nature chemical biology, 2008, Volume: 4, Issue:5

    Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imi

2008